The treatment is largely based on the treatment of anti-NMDAR encephalitis which is the most common autoimmune encephalitis. Treatment of an associated tumour is implicated in all paraneoplastic neurologic syndromes. Case series have been published where treatment has consisted of combinations of IVIG, plasmapheresis, glucocorticoids/other immunosuppressant drugs and rituximab.
Anti-VGKC-complex encephalitis
Anti-NMDA receptor encephalitis
Anti-Hu associated encephalitis
Anti-neurofascin demyelinating diseases
Lymphocytic meningoradiculitis
Limbic encephalitis
Powassan encephalitis
Autoimmune encephalitis